IN CASE YOU MISSED IT: Clinical Leader Top 3 Articles For July 2016
By Ed Miseta, Chief Editor, Clinical Leader
Below are my top three articles downloaded on Clinical Leader for the month of July 2016. In case you missed them, please take this opportunity to see what everyone else was learning about GSK’s bold moves into mHealth, the efforts of Duke and PCORI to transform clinical trials, and the coming mHealth tsunami.
GSK's Bold Move Into Uncharted mHealth Waters
While some sponsor companies continue to fret over the challenges of incorporating mobile and wearable technologies into clinical trials, GSK is one sponsor that has been boldly moving forward. GSK’s thinking and efforts in this area are certainly attributes that others should emulate.
Duke & PCORI Use EHRs To Transform Clinical Trials
PCORI (Patient-Centered Outcomes Research Institute) and the Duke Clinical Research Institute have launched the ADAPTABLE study, a patient-centric trial designed to assess the benefits and long-term effectiveness of aspirin dosing. With a budget of over $14 million, the trial will randomize and dose 20,000 patients while leveraging health systems, EHRs (electronic health records), and patients in an attempt to fundamentally transform clinical research.
Are Your Clinical Trials Prepared For The Coming mHealth Tsunami?
Excitement around mHealth technologies has been building for years. While initial apprehension kept many companies from jumping into the space, sensors are finally starting to make it onto patients.
You might also enjoy:
Study Rescue: How To Get Your Clinical Trial Back On Track
Combining PROs And Clinical Data To Benefit Cancer Patients & Researchers